- Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
- Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
- The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.
Speaker(s):
Michel Reid
Global Head of Demographics & Diversity
GSK
Alana Miller
Associate Director, Diversity in Clinical Trials
Merck
Monique Adams
Executive Director, Diversity & Inclusion in Clinical Trials
Sanofi